Why the study?
Does comprehensive risk factor control (blood pressure, LDL cholesterol, HbA1c, and smoking) reduce the incidence of cardiovascular disease in Japanese hypertensive patients treated with olmesartan?
Does comprehensive risk factor control (blood pressure, LDL cholesterol, HbA1c, and smoking) reduce the incidence of cardiovascular disease in Japanese hypertensive patients treated with olmesartan?
Comprehensive control of multiple risk factors (blood pressure, LDL cholesterol, HbA1c, and smoking) is crucial for the primary prevention of cardiovascular disease in hypertensive patients, as a lack of controlled factors exponentially increases CVD risk.
No takes yet. Share an insight, caveat, or question.
Supports comprehensive risk factor control in hypertensives; leaves open causality and incremental value of dyslipidemia management.
Teramoto et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: